Glial cell response: A pathogenic factor in Parkinson's disease

被引:26
|
作者
Wu, DC
Tieu, K
Cohen, O
Choi, DK
Vila, M
Jackson-Lewis, V
Teismann, P
Przedborski, S
机构
[1] Columbia Univ, Dept Neurol, Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY USA
关键词
astrocyte; gliosis; IL-1; beta; iNOS; microglia; MPTP; neurodegeneration; Parkinson's disease;
D O I
10.1080/13550280290100905
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, proinflammatory prostaglandin, and cytokines. In this review, the authors discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how these factors; may contribute to the pathogenesis of this disease.
引用
收藏
页码:551 / 558
页数:8
相关论文
共 50 条
  • [31] Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
    Steven S. Gill
    Nikunj K. Patel
    Gary R. Hotton
    Karen O'Sullivan
    Renée McCarter
    Martin Bunnage
    David J. Brooks
    Clive N. Svendsen
    Peter Heywood
    Nature Medicine, 2003, 9 : 589 - 595
  • [32] Glial phagocytic clearance in Parkinson’s disease
    Marie-Eve Tremblay
    Mark R. Cookson
    Laura Civiero
    Molecular Neurodegeneration, 14
  • [33] Apoptosis, glial cells and Parkinson's disease
    Hirsch, EC
    NEURONAL DEATH BY ACCIDENT OR DESIGN, 2002, : 97 - 107
  • [34] Glial iron sequestration and Parkinson's disease
    Schipper, HM
    JOURNAL OF NEUROCHEMISTRY, 1998, 70 : S76 - S76
  • [35] Glial phagocytic clearance in Parkinson's disease
    Tremblay, Marie-Eve
    Cookson, Mark R.
    Civiero, Laura
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [36] The role of glial cells in Parkinson's disease
    Vila, M
    Jackson-Lewis, V
    Guégan, C
    Wu, DC
    Teismann, P
    Choi, DK
    Tieu, K
    Przedborski, S
    CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) : 483 - 489
  • [37] Hippocampal neuron and glial cell numbers in Parkinson's disease - A stereological study
    Joelving, F. C.
    Billeskov, R.
    Christensen, J. R.
    West, M.
    Pakkenberg, B.
    HIPPOCAMPUS, 2006, 16 (10) : 826 - 833
  • [38] Level of glial neurotrophic factor in the blood plasma depending on the duration of Parkinson's disease
    Muminov, B.
    Matmurodov, R.
    Abduqodirov, E.
    MOVEMENT DISORDERS, 2022, 37 : S586 - S586
  • [39] The level of glial neurotrophic factor in blood plasma depending on the stage of Parkinson's disease
    Matmurodov, R.
    Muminov, M.
    Abduqodirov, A.
    Khalimova, K.
    MOVEMENT DISORDERS, 2022, 37 : S592 - S592
  • [40] Intermittent Intraputamenal Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease: Seeking the Path to Neurorestoration
    Cothros, Nicholas
    Medina, Alex
    Bruno, Veronica
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (04): : 280 - 281